Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve US trial
Objectives: The purpose of this study was to characterize health status outcomes after
transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis among …
transcatheter aortic valve replacement (TAVR) with a self-expanding bioprosthesis among …
Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: the UK Transcatheter Aortic Valve Implantation …
A Duncan, P Ludman, W Banya, D Cunningham… - JACC: Cardiovascular …, 2015 - jacc.org
Abstract Objectives: The UK Transcatheter Aortic Valve Implantation Registry reported 30-
day and 1-year mortality rates of 7.1% and 21.4%, respectively, for patients who underwent …
day and 1-year mortality rates of 7.1% and 21.4%, respectively, for patients who underwent …
TAVR in low-risk patients: 1-year results from the LRT trial
R Waksman, PJ Corso, R Torguson, P Gordon… - JACC: Cardiovascular …, 2019 - jacc.org
Objectives: This study sought to evaluate clinical outcomes and transcatheter heart valve
hemodynamics at 1 year after transcatheter aortic valve replacement (TAVR) in low-risk …
hemodynamics at 1 year after transcatheter aortic valve replacement (TAVR) in low-risk …
Prediction of poor outcome after transcatheter aortic valve replacement
Background: A series of models have been developed to identify patients at high risk for
poor outcomes after transcatheter aortic valve replacement (TAVR) to help guide treatment …
poor outcomes after transcatheter aortic valve replacement (TAVR) to help guide treatment …
5-Year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients
TG Gleason, MJ Reardon, JJ Popma, GM Deeb… - Journal of the American …, 2018 - jacc.org
Abstract Background: The CoreValve US Pivotal High Risk Trial was the first randomized
trial to show superior 1-year mortality of transcatheter aortic valve replacement (TAVR) …
trial to show superior 1-year mortality of transcatheter aortic valve replacement (TAVR) …
[HTML][HTML] Systematic review of the cost-effectiveness of transcatheter aortic valve implantation
P Indraratna, SC Ang, H Gada, TD Yan… - The Journal of thoracic …, 2014 - Elsevier
Objective Transcatheter aortic valve implantation (TAVI) has emerged as an alternative
treatment to aortic valve replacement (AVR) for selected patients with severe aortic stenosis …
treatment to aortic valve replacement (AVR) for selected patients with severe aortic stenosis …
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in low-risk patients
S Rosato, F Santini, M Barbanti, F Biancari… - Circulation …, 2016 - Am Heart Assoc
Background—The proven efficacy of transcatheter aortic valve implantation (TAVI) in high-
risk patients is leading to the expansion of its indications toward lower-risk patients …
risk patients is leading to the expansion of its indications toward lower-risk patients …
Transcatheter versus surgical aortic valve replacement in low-and intermediate-risk patients: an updated systematic review and meta-analysis
D Ueshima, LN Fovino, G D'Amico, SJ Brener… - Cardiovascular …, 2019 - Springer
Transcatheter aortic valve replacement (TAVR) has been recognized as a well-established
alternative to surgical aortic valve replacement (SAVR) for symptomatic aortic stenosis with …
alternative to surgical aortic valve replacement (SAVR) for symptomatic aortic stenosis with …
Expansion of TAVR into low-risk patients and who to consider for SAVR
KV Patel, W Omar, PE Gonzalez, ME Jessen… - Cardiology and …, 2020 - Springer
Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of severe
aortic stenosis (AS) over the last decade. The results of the Placement of Aortic …
aortic stenosis (AS) over the last decade. The results of the Placement of Aortic …
Contemporary costs associated with transcatheter versus surgical aortic valve replacement in medicare beneficiaries
SJ Baron, MP Ryan, KA Moore, SJ Clancy… - Circulation …, 2022 - Am Heart Assoc
Background: In patients with severe aortic stenosis, treatment with transcatheter aortic valve
replacement (TAVR) has been shown to be cost-effective in the high-risk surgical population …
replacement (TAVR) has been shown to be cost-effective in the high-risk surgical population …